Differential effect of chronic desipramine and amitriptyline treatment on rat brain adrenergic and serotonergic receptors

Psychiatry Res. 1981 Apr;4(2):129-38. doi: 10.1016/0165-1781(81)90016-0.

Abstract

Serotonergic and adrenergic receptors were examine in rat brains by direct binding assays after chronic treatment with tricyclic antidepressants. Chronic amitriptyline (AMT) treatment (10 mg/kg/day i.p. for 21 days) decreased specific 3H-spiperone binding in the cortex and not in the caudate nuclei. Specific 3H-dihydroalprenolol (3H-DHA) binding was reduced in cerebellar but not in cerebral cortex. Chronic desipramine (DMI) treatment given in the same dose schedule, on the other hand, decreased specific 3H-DHA binding in both cerebellar and cerebral cortex. Specific 3H-spiperone binding in the cerebral cortex was also reduced but to a lesser extent than that in the AMT treated group. Scatchard analysis showed that reductions in 3H-spiperone or 3H-DHA binding in all cases were due to decreases in number of binding sites (Bmax) and not to changes in dissociation constants (KD). No change was observed in 3H-serotonin (3H-5HT), 3H-clonidine, or 3H-WB-4101 binding. The results show that there is no single common change in brain adrenergic and serotonergic receptors after chronic AMT and DMI treatment.

MeSH terms

  • Amitriptyline / pharmacology*
  • Animals
  • Brain / drug effects*
  • Cerebral Cortex / drug effects
  • Clonidine / metabolism
  • Desipramine / pharmacology*
  • Dihydroalprenolol / metabolism
  • Dioxanes / metabolism
  • Male
  • Radioligand Assay
  • Rats
  • Receptors, Adrenergic / drug effects*
  • Receptors, Serotonin / drug effects*
  • Serotonin / metabolism
  • Spiperone / metabolism

Substances

  • Dioxanes
  • Receptors, Adrenergic
  • Receptors, Serotonin
  • Amitriptyline
  • Serotonin
  • Spiperone
  • Dihydroalprenolol
  • (2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane
  • Clonidine
  • Desipramine